Austar Lifesciences (HKSE:06118) Total Operating Expense: HK$285 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06118 Austar Lifesciences Ltd HKSE:06118
45 GF Score
Price HK$0.71
GF Value HK$0.97
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Austar Lifesciences Total Operating Expense?

Austar Lifesciences HKSE:06118 +1.43% 45 Total Operating Expense is HK$285 Mil as of Dec. 2025. GuruFocus rates HKSE:06118 with a GF Score™ of 45/100 and a GF Value™ of HK$0.97 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Austar Lifesciences's Total Operating Expense for the six months ended in Dec. 2025 was HK$148 Mil. Austar Lifesciences's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was HK$285 Mil.

Austar Lifesciences Total Operating Expense Related Terms

Austar Lifesciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Austar Lifesciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Austar Lifesciences Total Operating Expense Chart

Austar Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 438.46 408.00 377.42 283.02 286.74

Austar Lifesciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 163.33 139.96 144.21 137.05 148.22
HKSE:06118
45GF Score
Austar Lifesciences Ltd HKSE:06118
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Austar Lifesciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$285 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of HK$285 Mil mean?
Austar Lifesciences (HKSE:06118) has a Total Operating Expense of HK$285 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Austar Lifesciences and its competitors.
Is Austar Lifesciences' Total Operating Expense too high?
Austar Lifesciences' current Total Operating Expense is HK$285 Mil. Overall, Austar Lifesciences has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Austar Lifesciences' Total Operating Expense compare to ABT and SYK?
Austar Lifesciences' Total Operating Expense of HK$285 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Austar Lifesciences and its competitors. Austar Lifesciences's current Total Operating Expense is HK$285 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austar Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Austar Lifesciences (HKSE:06118) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.97, compared to a current price of HK$0.71 — trading 26.8% below its estimated fair value. The current Total Operating Expense is HK$285 Mil. Austar Lifesciences' overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Austar Lifesciences (HKSE:06118), the current Total Operating Expense is HK$285 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Austar Lifesciences (HKSE:06118) Overvalued in 2026?

Based on GuruFocus' analysis, Austar Lifesciences stock appears to be undervalued. The current stock price of HK$0.71 is trading 26.8% below its estimated GF Value™ of HK$0.97. GuruFocus considers Austar Lifesciences to be Modestly Undervalued.

Key valuation signals for HKSE:06118:

  • Total Operating Expense: HK$285 Mil
  • GF Value™: HK$0.97 vs. price of HK$0.71 (26.8% below fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the HKSE:06118 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Austar Lifesciences Business Description

Other Exchanges AULSF:USA
Address No.1018 Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN
Austar Lifesciences Ltd is an investment holding company, and its subsidiaries are principally engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipment and consumables in the PRC. Its products include Clean Utility Equipment & Chemical Pharmaceutical Preparation System and others. It has three business segment groups: Integrated Process and Packaging Equipment & Systems (IPS), which generates maximum revenue and combines the original business segments of Liquid and Bioprocess System and Powder and Solid System; Consulting, Digitalization, and Construction; and Life Science Equipment and Consumables. The Group generates maximum revenue from Mainland China.
45GF Score

Get the complete analysis for HKSE:06118

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.71
Price
HK$0.97
GF Value